Oxford BioDynamics Crecimiento futuro
Future controles de criterios 2/6
Oxford BioDynamics's earnings are forecast to decline at 4.5% per annum while its annual revenue is expected to grow at 85.3% per year. EPS is expected to grow by 32.1% per annum.
Información clave
-4.5%
Tasa de crecimiento de los beneficios
32.1%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Life Sciences | 19.8% |
Tasa de crecimiento de los ingresos | 85.3% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Low |
Última actualización | 18 Oct 2024 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Here's Why We're Watching Oxford BioDynamics' (LON:OBD) Cash Burn Situation
Jan 18Here's Why We're A Bit Worried About Oxford BioDynamics' (LON:OBD) Cash Burn Situation
Oct 08Is Oxford BioDynamics (LON:OBD) In A Good Position To Invest In Growth?
Sep 21Oxford BioDynamics (LON:OBD) Is In A Good Position To Deliver On Growth Plans
May 24We're Not Very Worried About Oxford BioDynamics' (LON:OBD) Cash Burn Rate
Dec 07Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
9/30/2025 | 2 | -12 | N/A | -10 | 1 |
9/30/2024 | 1 | -11 | N/A | -10 | 1 |
3/31/2024 | 1 | -11 | -7 | -7 | N/A |
12/31/2023 | 1 | -11 | -8 | -7 | N/A |
9/30/2023 | 1 | -11 | -9 | -8 | N/A |
6/30/2023 | 0 | -10 | -9 | -8 | N/A |
3/31/2023 | 0 | -8 | -9 | -8 | N/A |
12/31/2022 | 0 | -7 | -7 | -7 | N/A |
9/30/2022 | 0 | -7 | -6 | -5 | N/A |
6/30/2022 | 0 | -7 | -7 | -5 | N/A |
3/31/2022 | 0 | -6 | -9 | -5 | N/A |
12/31/2021 | 0 | -7 | -9 | -6 | N/A |
9/30/2021 | 0 | -7 | -9 | -6 | N/A |
6/30/2021 | 0 | -6 | -7 | -5 | N/A |
3/31/2021 | 1 | -5 | -6 | -5 | N/A |
12/31/2020 | 0 | -5 | -5 | -4 | N/A |
9/30/2020 | 0 | -4 | -4 | -3 | N/A |
6/30/2020 | 0 | -4 | -4 | -3 | N/A |
3/31/2020 | 1 | -4 | -3 | -3 | N/A |
12/31/2019 | 1 | -3 | -3 | -3 | N/A |
9/30/2019 | 1 | -3 | -3 | -2 | N/A |
6/30/2019 | 1 | -2 | -3 | -2 | N/A |
3/31/2019 | 1 | -2 | -3 | -2 | N/A |
12/31/2018 | 1 | -2 | -3 | -2 | N/A |
9/30/2018 | 1 | -2 | -3 | -2 | N/A |
6/30/2018 | 1 | -2 | -2 | -2 | N/A |
3/31/2018 | 1 | -2 | -2 | -1 | N/A |
12/31/2017 | 1 | -3 | N/A | -1 | N/A |
9/30/2017 | 1 | -4 | N/A | -2 | N/A |
6/30/2017 | 1 | -4 | N/A | -1 | N/A |
3/31/2017 | 1 | -4 | N/A | -1 | N/A |
12/31/2016 | 1 | -3 | N/A | -1 | N/A |
9/30/2016 | 1 | -2 | N/A | -1 | N/A |
6/30/2016 | 1 | -2 | N/A | -2 | N/A |
3/31/2016 | 1 | -1 | N/A | -2 | N/A |
12/31/2015 | 1 | -1 | N/A | -2 | N/A |
9/30/2015 | 1 | -1 | N/A | -1 | N/A |
9/30/2014 | 1 | -1 | N/A | 0 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: OBD is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: OBD is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: OBD is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: OBD's revenue (85.3% per year) is forecast to grow faster than the UK market (3.6% per year).
Ingresos de alto crecimiento: OBD's revenue (85.3% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if OBD's Return on Equity is forecast to be high in 3 years time